Here are relevant reports on : genomic-diagnostics-market
-
Cancer Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
The global cancer profiling market in terms of revenue was estimated to be worth $9.7 billion in 2022 and is poised to reach $16.0 billion by 2027, growing at a CAGR of 10.6% from 2022 to 2027. The growth in this market is driven by rising funding investments in cancer research and technological advancements in profiling technologies. In addition, the growing need for point-of-care diagnostics is expected to offer significant growth opportunities for market players. On the other hand, a low biomarker discovery-to-approval ratio and a poor regulatory and reimbursement scenario challenge the growth of the cancer profiling market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030
The global lab automation market, valued at US$5.97 billion in 2024, stood at US$6.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.2% from 2025 to 2030, culminating in a forecasted valuation of US$9.01 billion by the end of the period. The primary driver of this growth is the increasing demand for high-throughput screening, which enables laboratories to efficiently process large volumes of samples in drug discovery and diagnostics.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region - Global Forecast to 2030
The global Artificial Intelligence (AI) in healthcare market, valued at US$14.92B in 2024, is forecasted to grow at a 38.6% CAGR, reaching US$21.66B by 2025 and US$110.61B by 2030. Market growth in the Asia Pacific can be attributed to the presence of a large and growing patient population, a gradual shift toward adopting technologies such as automation, data analytics, and cloud computing, and increasing spending on HCIT infrastructure.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Analytical Testing Services Market by Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030
The global healthcare analytical testing services market, valued at US$6.33 billion in 2023, stood at US$7.48 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$12.48 billion by the end of the period. The key factors contributing to market growth include stringent regulatory guidelines, a growing focus on analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical and medical device companies, and the rising acceptance of a quality-by-design approach in pharmaceutical research and manufacturing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030
The global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Molecular Breeding Market by Process (QTL Mapping, Marker-Assisted Selection, Marker-Assisted Backcrossing, and Genomic Selection), Marker (SNP, SSR), Application (Crop Breeding and Livestock Breeding), and Region-Global Forecast to 2023
The molecular breeding market is estimated at USD 1.79 billion in 2018 and is projected to reach USD 3.95 billion by 2023, at a CAGR of 17.11% during the forecast period. The agricultural benefits associated with these adjuvant solutions are the major factors contributing to the growth of this market, globally. The growth of economies in developing countries, coupled with the increasing R&D expenses in the agriculture industry drives the growth potential of these markets.The global market for molecular breeding is dominated by key players such as Eurofins (Luxembourg), Illumina (US), LGC Limited (UK), Thermo Fisher Scientific (US), and SGS (Switzerland). Some emerging players in the molecular breeding market include DanBred (Denmark), Intertek Group (UK), LemnaTec (Germany), Charles River (US), Slipstream Automation (New Zealand), and Fruitbreedomics (consortium).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User & Region - Global Forecast to 2025
The global veterinary PoC diagnostics market growth is primed to transition from $1.4 billion in 2019 to $2.4 billion by 2025, showcasing a strong CAGR of 8.9%. Key drivers include the rising prevalence of zoonotic diseases in animals and the need for rapid diagnostics, though high costs of imaging equipment pose a challenge.
- Published: May 2020
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
